TPO and Graves disease: Furthermore, patients who had TPO autoantibodies developed Graves’ disease after discontinuation of immune suppressive therapy that followed Thymoglobulin induction therapy, suggesting that the immune system lost its capacity to suppress autoreactive T cells [8].